Successful Interim Outcomes of Bortezomib Desensitization on Highly Sensitized Deceased Donor Kidney Transplant Waitlist Patients

Successful Interim Outcomes of Bortezomib Desensitization on Highly Sensitized Deceased Donor Kidney Transplant Waitlist Patients

Highly sensitized (HS) patients seldom have chance to receive kidney transplant. To increase transplantation rate among those population, previous IV immunoglobulin and rituximab desensitization protocol showed good transplant conversion rate, but also carried moderate rate of antibody mediated reje...

Full description

Bibliographic Details
Main Authors: Jong Cheol Jeong, Hyuk Yong Kwon, Tai Yeon Koo, Hee Jung Jeon, Miyeun Han, Kook-Hwan Oh, Curie Ahn, Jaeseok Yang
Format: Article
Language:English
Published: The Korean Society of Nephrology 2014-06-01
Series:Kidney Research and Clinical Practice
Online Access:http://www.sciencedirect.com/science/article/pii/S2211913214000497

Similar Items

Similar Items